Agency Forms Undergoing Paperwork Reduction Act Review, 41415-41416 [2017-18512]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 168 / Thursday, August 31, 2017 / Notices
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than
September 14, 2017.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. James C. Volkert, individually and
as trustee of the James C. Volkert
Revocable Living Trust, the James C.
Volkert Revocable Living Trust, Susan
A. Volkert, Jacquelyn Volkert, and
Michael Volkert, all of Montgomery,
Illinois; as a group acting in concert to
retain voting shares of Montgomery
Bancshares, Inc., and thereby indirectly
retain voting shares of Bank of
Montgomery, both in Montgomery,
Illinois.
B. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Jeff Schumacher, Lincoln,
Nebraska; to acquire voting shares of
North Central Bancorp, Inc., and thereby
indirectly acquire BankFirst, both in
Norfolk, Nebraska.
Board of Governors of the Federal Reserve
System, August 25, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–18445 Filed 8–30–17; 8:45 am]
Proposed Project
The National Violent Death Reporting
System (NVDRS)(OMB Control Number
0920–0607, expiration 10/31/2017)—
Revision—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–0607]
sradovich on DSK3GMQ082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
VerDate Sep<11>2014
20:54 Aug 30, 2017
Jkt 241001
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Background and Brief Description
Violence is a public health problem.
The World Health Organization has
estimated that 804,000 suicides and
475,000 homicides occurred in the year
2012 worldwide. Violence in the United
States is a particular problem for the
young; suicide and homicide were
among the top 4 leading causes of death
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
41415
for Americans 10–34 and 1–34 years of
age in 2015, respectively. In 2002
Congress approved the first
appropriation to start the National
Violent Death Reporting System
(NVDRS). NVDRS is coordinated and
funded at the federal level but is
dependent on separate data collection
efforts managed by the state health
department (or their bona fide agent) in
each state.
NVDRS is an ongoing surveillance
system that captures annual violent
death counts and circumstances that
precipitate each violent incident. Data
on violent death is defined as a death
resulting from the intentional use of
physical force or power (e.g., threats or
intimidation) against oneself, another
person, or against a group or
community. CDC aggregates deidentified data from each state into one
large national database that is analyzed
and released in annual reports and
publications. Descriptive analyses such
as frequencies and rates are employed.
A restricted access database is available
for researchers to request access to
NVDRS data for analysis and a webbased query system is open for public
use that allows for electronic querying
of data. NVDRS generates public health
surveillance information at the national,
state, and local levels that is more
detailed, useful, and timely.
Government, state and local
communities have used NVDRS data to
develop and evaluate prevention
programs and strategies. NVDRS is also
used to understand magnitude, trends,
and characteristics of violent death and
what factors protect people or put them
at risk for experiencing violence.
This is a revision request for an
additional three years to continue data
collection efforts of the currently
approved information collection project.
The purpose of this revision is to (1)
implement updates to the web-based
system to improve performance,
functionality, and accessibility; (2) add
new data elements to the system and
minimal revisions to the NVDRS coding
manual; (3) modify burden hours to
account for the increase in violent
deaths in the U.S. since 2003; and (4) to
decrease the number of funded
reporting state health departments from
58 to 56.
The estimated annual burden hours
are 34,250. There are no costs to
respondents.
E:\FR\FM\31AUN1.SGM
31AUN1
41416
Federal Register / Vol. 82, No. 168 / Thursday, August 31, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Form name
Number of
respondents
Total number
of responses
per
respondent
Average
burden per
response
(in hours)
Public Agencies ..............................................
Retrieving and refile records ..........................
56
1,223
30/60
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–18512 Filed 8–30–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–N–4565]
Electronic Study Data Submission;
Data Standards; Support for Version
Update of the Medical Dictionary for
Regulatory Activities
AGENCY:
Written/Paper Submissions
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing support for the most current
version of Medical Dictionary for
Regulatory Activities (MedDRA), end of
support for earlier versions of MedDRA,
and an update to the FDA Data
Standards Catalog (Catalog) for study
data provided in new drug applications
(NDAs), abbreviated new drug
applications (ANDAs), biologics license
applications (BLAs), and investigational
new drug applications (INDs) to the
Center for Biologics Evaluation and
Research (CBER) and the Center for
Drug Evaluation and Research (CDER).
DATES: Submit either electronic or
written comments on this document at
any time.
ADDRESSES: You may submit comments
as follows:
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
Electronic Submission
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
VerDate Sep<11>2014
20:54 Aug 30, 2017
Jkt 241001
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2017–N–4565 for ‘‘Electronic Study
Data Submission; Data Standards;
Support for Version Update of the
Medical Dictionary for Regulatory
Activities.’’ Received comments will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Ron
Fitzmartin, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 51, Rm. 1115, Silver Spring,
MD 20993–0002, 301–796–5333,
cderdatastandards@fda.hhs.gov; or
Stephen Ripley, Center for Biologics
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7268,
Silver Spring, MD 20993–0002, 240–
402–7911, stephen.ripley@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On
December 17, 2014, FDA published final
guidance for industry ‘‘Providing
Regulatory Submissions in Electronic
Format—Standardized Study Data’’
(eStudy Data) posted on FDA’s Study
Data Standards Resources Web page at
https://www.fda.gov/forindustry/
datastandards/studydatastandards/
default.htm. The eStudy Data guidance
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 82, Number 168 (Thursday, August 31, 2017)]
[Notices]
[Pages 41415-41416]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18512]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-0607]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
The National Violent Death Reporting System (NVDRS)(OMB Control
Number 0920-0607, expiration 10/31/2017)--Revision--National Center for
Injury Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Violence is a public health problem. The World Health Organization
has estimated that 804,000 suicides and 475,000 homicides occurred in
the year 2012 worldwide. Violence in the United States is a particular
problem for the young; suicide and homicide were among the top 4
leading causes of death for Americans 10-34 and 1-34 years of age in
2015, respectively. In 2002 Congress approved the first appropriation
to start the National Violent Death Reporting System (NVDRS). NVDRS is
coordinated and funded at the federal level but is dependent on
separate data collection efforts managed by the state health department
(or their bona fide agent) in each state.
NVDRS is an ongoing surveillance system that captures annual
violent death counts and circumstances that precipitate each violent
incident. Data on violent death is defined as a death resulting from
the intentional use of physical force or power (e.g., threats or
intimidation) against oneself, another person, or against a group or
community. CDC aggregates de-identified data from each state into one
large national database that is analyzed and released in annual reports
and publications. Descriptive analyses such as frequencies and rates
are employed. A restricted access database is available for researchers
to request access to NVDRS data for analysis and a web-based query
system is open for public use that allows for electronic querying of
data. NVDRS generates public health surveillance information at the
national, state, and local levels that is more detailed, useful, and
timely. Government, state and local communities have used NVDRS data to
develop and evaluate prevention programs and strategies. NVDRS is also
used to understand magnitude, trends, and characteristics of violent
death and what factors protect people or put them at risk for
experiencing violence.
This is a revision request for an additional three years to
continue data collection efforts of the currently approved information
collection project. The purpose of this revision is to (1) implement
updates to the web-based system to improve performance, functionality,
and accessibility; (2) add new data elements to the system and minimal
revisions to the NVDRS coding manual; (3) modify burden hours to
account for the increase in violent deaths in the U.S. since 2003; and
(4) to decrease the number of funded reporting state health departments
from 58 to 56.
The estimated annual burden hours are 34,250. There are no costs to
respondents.
[[Page 41416]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Total number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Public Agencies..................... Retrieving and refile 56 1,223 30/60
records.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-18512 Filed 8-30-17; 8:45 am]
BILLING CODE 4163-18-P
